| Bioactivity | Acrixolimab a humanized IgG4-κ antibody, targeting to PD-1[1][2]. |
| Name | Acrixolimab |
| CAS | 2506324-29-2 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kiratikanon S, et al. Acrixolimab-Induced Radiation Recall Dermatitis with Distinct Features Resembling Erythema Multiforme[J]. Thai Journal of Dermatology, 2023, 39(2): 35-38. [2]. Acrixolimab. IMGT/mAb-DB. |